GB1444980A - Psychotropic medicinal preparation - Google Patents
Psychotropic medicinal preparationInfo
- Publication number
- GB1444980A GB1444980A GB5522473A GB5522473A GB1444980A GB 1444980 A GB1444980 A GB 1444980A GB 5522473 A GB5522473 A GB 5522473A GB 5522473 A GB5522473 A GB 5522473A GB 1444980 A GB1444980 A GB 1444980A
- Authority
- GB
- United Kingdom
- Prior art keywords
- preparations
- medicinal preparation
- pharmaceutical
- psychotropic
- tripthasine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
1444980 Antidepressants VSES N I KHIMKO-FARMATSEVTICHE INST IM S ORDZHONIKIDZE 28 Nov 1973 55224/73 Heading A5B Pharmaceutical preparations having antidepressant activity comprise a salt of 3-methyl- 8-methoxy-3H, 1, 2, 5, 6-tetrahydropyrazino-(1, 2, 3,-ab)-beta-carboline of formula where A is a pharmaceutically acceptable inorganic or organic acid particularly hydrochloric or bitartaric acid, together with a pharmaceutical carrier or diluent. The preparations may be administered orally, parenterally or rectally in the form of injectable solutions, tablets, pills, lozenges, linctuses, syrups, suppositories or aerosols. The preparations may also contain neuroleptics, such as Tripthasine, Itaperazin'e and/or Sonapax. Reference has been directed by the comptroller to Specification 1409935.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU721850615A SU788471A1 (en) | 1972-11-28 | 1972-11-28 | Psychotropic agent "inkazan" for treating depressive states |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1444980A true GB1444980A (en) | 1976-08-04 |
Family
ID=20533240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5522473A Expired GB1444980A (en) | 1972-11-28 | 1973-11-28 | Psychotropic medicinal preparation |
Country Status (4)
Country | Link |
---|---|
DE (1) | DE2356091A1 (en) |
FR (1) | FR2207727B1 (en) |
GB (1) | GB1444980A (en) |
SU (1) | SU788471A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004113300A1 (en) * | 2003-06-23 | 2004-12-29 | Ono Pharmaceutical Co., Ltd. | Novel tricyclic heterocycle compound |
US7964726B2 (en) | 2004-12-22 | 2011-06-21 | Ono Pharmaceutical Co., Ltd. | Tricyclic compound and use thereof |
-
1972
- 1972-11-28 SU SU721850615A patent/SU788471A1/en active
-
1973
- 1973-11-09 DE DE2356091A patent/DE2356091A1/en active Pending
- 1973-11-28 GB GB5522473A patent/GB1444980A/en not_active Expired
- 1973-11-28 FR FR7342414A patent/FR2207727B1/fr not_active Expired
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004113300A1 (en) * | 2003-06-23 | 2004-12-29 | Ono Pharmaceutical Co., Ltd. | Novel tricyclic heterocycle compound |
US7872133B2 (en) | 2003-06-23 | 2011-01-18 | Ono Pharmaceutical Co., Ltd. | Tricyclic heterocycle compound |
US7964726B2 (en) | 2004-12-22 | 2011-06-21 | Ono Pharmaceutical Co., Ltd. | Tricyclic compound and use thereof |
US8476293B2 (en) | 2004-12-22 | 2013-07-02 | Ono Pharmaceutical Co., Ltd. | Tricyclic compound and use thereof |
US8952158B2 (en) | 2004-12-22 | 2015-02-10 | Ono Pharmaceutical Co., Ltd. | Tricyclic compound and use thereof |
Also Published As
Publication number | Publication date |
---|---|
FR2207727B1 (en) | 1977-09-02 |
SU788471A1 (en) | 1981-12-30 |
DE2356091A1 (en) | 1974-07-04 |
FR2207727A1 (en) | 1974-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1274271A (en) | Improvements in or relating to propionic acid derivatives | |
GB1380171A (en) | Medicinal tablets | |
GB1503675A (en) | Compositions based on pyrimidine derivatives and their use in the treatment of viral infections | |
GB1458048A (en) | Pharmaceutical composition | |
GB1444980A (en) | Psychotropic medicinal preparation | |
GB1502873A (en) | Pharmaceutical compositions with ulcer healing activity | |
GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
GB1291559A (en) | N-(4-chlorocinnamoyl)-4-hydroxypiperidine | |
GB1153640A (en) | A Carnitin Salt | |
GB1368375A (en) | 4-/4-biphenylzl/-1-butanols | |
GB1277847A (en) | Sulphonyl ureas | |
GB1152627A (en) | Improvements in or relating to Oxazole Derivatives | |
GB971243A (en) | Substituted 4-phenylaminoquinolines | |
GB1341376A (en) | Pharmaceutical compositions comprising 4-methyl-5-2-aminoethyl imidazole | |
GB1439240A (en) | Chewable aspirin tablet | |
GB1304697A (en) | ||
GB1263839A (en) | A novel aminoethanesulfonic acid | |
GB1352392A (en) | Phenylisopropylamine derivatives | |
GB1154454A (en) | New Anthranilic Acid Derivatives | |
GB1177411A (en) | Improvements in and relating to Pharmaceutical Compositions | |
GB1257264A (en) | ||
SE329398B (en) | ||
GB1415228A (en) | Pharmacologically active acetic acid derivatives | |
GB1247783A (en) | Production of indole acetaldehydes | |
GB1167688A (en) | Dealkylation of Cyclic N-alkyl Derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |